Medpace Holdings Inc vs Western Union Co — how do they compare? Medpace Holdings Inc trades at $519.93 (market cap $15.08B), while Western Union Co trades at $8.81 (market cap $2.71B). The key difference: Medpace Holdings Inc is far larger — about 5.6× Western Union Co's market cap, and Western Union Co pays a 10.85% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | WU | |
|---|---|---|
Market Cap | $15.08B | $2.71B |
Sector | Technology | Technology |
52-Week High | $620.59 | $10.28 |
52-Week Low | $308.88 | $7.04 |
Enterprise Value | $14.55B | $2.40B |
Dividend Yield | — | 10.85% |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Western Union (WU) trades at $8.65, down 2.59% on the day, with strong valuation metrics including a P/E of 6.53 and P/S of 0.71. The company maintains profitability with a 10.88% net margin and 47.66% ROE, though Q1 2026 earnings missed expectations. Recent developments include strategic partnerships with Total Wireless and Bybit, and the pending acquisition of Intermex. Technical indicators show mixed signals with bullish moving averages but overbought RSI levels.
WU presents a value opportunity with attractive dividend yield and low valuation multiples, but faces revenue decline and margin pressure. The stock trades above analyst consensus target of $7.83, suggesting limited near-term upside. Key risks include declining traditional remittance business and execution challenges in digital transformation. Institutional sentiment remains cautious with only 12.5% buy ratings.
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →